Keli McLoyd’s class visit focused on the pharmaceutically assisted treatment for recovery – a touchy topic for those in the recovery world. Sharing data sources about mental health, and her own team’s work in pharmaceutical research, Keli provided us with clear information about this approach to recovery.

It’s a strange catch 22: these medications are used to kick addictions, but often end in a dependance of its own. In many recovery circles, this conflicts with the ‘abstinent’ mentality that prevails, creating yet another stigma attached to addiction. This treatment also has a difficult time gaining support as communities acknowledge their growing necessity, yet refuse to allow them near residential areas or schools. Plus, this method of treatment requires a lot of funding, most of which is currently hanging in the balance with the ACA. Medication-assisted recovery has a reputation that waivers between helpful and enabling.

Whether or not consistently using meds in recovery is considered actually being sober can be a gray area among addiction discourse, yet the bottom line seems to be that if it works for you, and keeps you within your definition of sobriety, it’s a valid option.